Stonebridge Capital Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-800
Closed -$23K – 1037
2021
Q4
$23K Hold
800
– – ﹤0.01% 485
2021
Q3
$26K Hold
800
– – ﹤0.01% 441
2021
Q2
$28K Hold
800
– – ﹤0.01% 436
2021
Q1
$24K Buy
+800
New +$24.6K ﹤0.01% 471
2020
Q3
– Sell
-800
Closed -$17K – 337
2020
Q2
$17K Hold
800
– – ﹤0.01% 421
2020
Q1
$18K Hold
800
– – ﹤0.01% 400
2019
Q4
$24K Hold
800
– – ﹤0.01% 421
2019
Q3
$21K Buy
800
+200
+33% +$6K ﹤0.01% 436
2019
Q2
$20K Buy
+600
New +$19.5K ﹤0.01% 451

Other funds holding ELAN

Stonebridge Capital Advisors's ELAN Position: Q1 2022 in Review

Stonebridge Capital Advisors sold out of Elanco Animal Health (ELAN) in Q1 2022, closing a stake of 800 shares — an estimated $23K sold.

Stonebridge Capital Advisors first reported a position in ELAN in Q2 2019 and held it in 9 quarters. The position peaked at $28K in Q2 2021. 472 funds tracked by Wall St. Rank hold ELAN as of Q1 2022.

  • Stonebridge Capital Advisors reported no remaining Elanco Animal Health position as of Q1 2022 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 800 Elanco Animal Health shares in Q1 2022, an estimated $23K.
  • Stonebridge Capital Advisors first reported a position in Elanco Animal Health in Q2 2019 and held it in 9 quarters.
  • Stonebridge Capital Advisors's Elanco Animal Health position peaked at $28K in Q2 2021.
  • 472 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2022.

Based on Stonebridge Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.